| Study |
Reference |
|
Bruno, 2024
|
Bruno Antipsychotic use during pregnancy and risk of specific neurodevelopmental disorders and learning difficulties in children: a multinational cohort study. EClinicalMedicine 2024; 70:102531
|
|
Chan (Controls exposed to FGA), 2024
|
Chan Risk of congenital malformations associated with first-trimester exposure to antipsychotics: A propensity score-weighted population-based cohort study. Eur Psychiatry 2024; 67:e42
|
|
Chan (Controls unexposed, general pop), 2024
|
Chan Risk of congenital malformations associated with first-trimester exposure to antipsychotics: A propensity score-weighted population-based cohort study. Eur Psychiatry 2024; 67:e42
|
|
Chan (Controls unexposed, sick), 2024
|
Chan Risk of congenital malformations associated with first-trimester exposure to antipsychotics: A propensity score-weighted population-based cohort study. Eur Psychiatry 2024; 67:e42
|
|
Ellfolk (Controls exposed to FGA), 2021
|
Ellfolk Second-generation antipsychotic use during pregnancy and risk of congenital malformations. Eur J Clin Pharmacol 2021; 77:1737-1745
|
|
Ellfolk (Controls unexposed NOS), 2021
|
Ellfolk Second-generation antipsychotic use during pregnancy and risk of congenital malformations. Eur J Clin Pharmacol 2021; 77:1737-1745
|
|
Huybrechts (Controls unexposed, NOS), 2023
|
Huybrechts The impact of in-utero antipsychotic drug exposure on congenital malformations: An international cohort study Pharmacoepidemiol Drug Saf 2021; 30 Suppl 1:3-439 Huybrechts Association of In Utero Antipsychotic Medication Exposure With Risk of Congenital Malformations in Nordic Countries and the US. JAMA Psychiatry 2023; 80:156-166 Huybrechts Antipsychotic Use in Pregnancy and the Risk for Congenital Malformations. JAMA Psychiatry 2016; 73:938-46 Liu Maternal antipsychotic use during pregnancy and congenital malformations. Am J Obstet Gynecol MFM 2023; 5:100950
|
|
Huybrechts (Controls unexposed, sick), 2023
|
Huybrechts The impact of in-utero antipsychotic drug exposure on congenital malformations: An international cohort study Pharmacoepidemiol Drug Saf 2021; 30 Suppl 1:3-439 Huybrechts Association of In Utero Antipsychotic Medication Exposure With Risk of Congenital Malformations in Nordic Countries and the US. JAMA Psychiatry 2023; 80:156-166 Huybrechts Antipsychotic Use in Pregnancy and the Risk for Congenital Malformations. JAMA Psychiatry 2016; 73:938-46 Liu Maternal antipsychotic use during pregnancy and congenital malformations. Am J Obstet Gynecol MFM 2023; 5:100950
|
|
Ishikawa, 2024
|
Ishikawa Association between exposure to atypical antipsychotics during pregnancy and risk of miscarriage. Acta Psychiatr Scand 2024; 150:562-572
|
|
Newport, 2007
|
Newport DJ Atypical antipsychotic administration during late pregnancy: placental passage and obstetrical outcomes. Am J Psychiatry 2007;164:1214-20
|
|
Ozturk, 2016
|
Ozturk Z Safety of psychotropic medications in pregnancy: An observational cohort study Klinik Psikofarmakoloji Bulteni 2016; 26:229-237.
|
|
Park, 2018
|
Park Y Continuation of Atypical Antipsychotic Medication During Early Pregnancy and the Risk of Gestational Diabetes. Am J Psychiatry. 2018 Jun 1;175(6):564-574
|
|
Peng, 2013
|
Peng M Effects of prenatal exposure to atypical antipsychotics on postnatal development and growth of infants: a case-controlled, prospective study. Psychopharmacology (Berl) 2013;228:577-84
|
|
Raguideau, 2017
|
Raguideau F Exposition in utero à l'acide valproïque et aux autres traitements de l'épilepsie et des troubles bipolaires et risque de malformations congénitales majeures (MCM) en France Agence nationale de sécurité du médicament et des produits de santé 2015:1-116
|
|
Reis (Control exposed to FGA), 2008
|
Reis M Maternal use of antipsychotics in early pregnancy and delivery outcome. J Clin Psychopharmacol 2008;28:279-88
|
|
Reis (Unexposed control, NOS), 2008
|
Reis M Maternal use of antipsychotics in early pregnancy and delivery outcome. J Clin Psychopharmacol 2008;28:279-88
|
|
Sadowski, 2013
|
Sadowski A Pregnancy outcomes following maternal exposure to second-generation antipsychotics given with other psychotropic drugs: a cohort study. BMJ Open 2013;3:
|
|
Shechtman (Control exposed to Haloperidol), 2009
|
Shechtman S Pregnancy outcome after in-utero exposure to risperidone: prospective controlled cohort study 20th Annual meeting of the European Network of Teratology Information Services, Florence; May 2009
|
|
Shechtman (Unexposed control), 2009
|
Shechtman S Pregnancy outcome after in-utero exposure to risperidone: prospective controlled cohort study 20th Annual meeting of the European Network of Teratology Information Services, Florence; May 2009
|
|
Sorensen, 2015
|
Sorensen MJ Risk of Fetal Death after Treatment with Antipsychotic Medications during Pregnancy. PLoS One 2015;10:e0132280
|
|
Straub, 2022
|
Straub Association of Antipsychotic Drug Exposure in Pregnancy With Risk of Neurodevelopmental Disorders: A National Birth Cohort Study. JAMA Intern Med 2022; 182:522-533
|
|
Vigod, 2015
|
Vigod SN Antipsychotic drug use in pregnancy: high dimensional, propensity matched, population based cohort study. BMJ 2015;350:h2298
|
|
Wang - HK cohort, 2021
|
Wang Association between antipsychotic use in pregnancy and the risk of gestational diabetes: Population-based cohort studies from the United Kingdom and Hong Kong and an updated meta-analysis. Schizophr Res 2021; 229:55-62
|
|
Yaris, 2005
|
Yaris Psychotropic drugs in pregnancy: a case-control study. Prog. Neuropsychopharmacol. Biol. Psychiatry 2005; 29:333-8
|
